Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000441243 | SCV000521134 | likely pathogenic | not provided | 2016-12-27 | criteria provided, single submitter | clinical testing | The Y835C variant, described as Y832C, was reported in an individual with androgen resistance caused by an amnio acid substitution in the ligand binding domain in AR (McPhaul et al, 1992). It was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. Y835C is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position within the ligand binding domain that is conserved across species and in silico analysis predicts this variant is probably damaging to the protein structure/function. Missense variants in nearby residues (L831V/F, R832L/Q, L839V/F, R841G/C/S) have been reported in the Human Gene Mutation Database in association with androgen insensitivity syndrome (Stenson et al., 2014), supporting the functional importance of this region of the protein. As the AR gene has a low rate of benign missense variants and missense variants are a common mechanism of disease, this variant is likely pathogenic; however, the possibility that it is benign cannot be excluded. |